Scientists experimented using an animal model.
The researchers say that the strategy to reduce the level of inflammation or prevent it, can become a cancer treatment.
This writes the Chronicle.info with reference to medikforum.ru.
Scientists from the cancer center at the Medical center of Diaconescu Beth Israel (BIDMC) prove: therapeutic methods that prevent inflammation that can prevent the growth of cancerous tumors. In particular, they propose to use the concept of anti-inflammatory to protect from re-occurrence of tumors following the traditional metalov cancer treatment.
“Surgery, chemotherapy, radiation therapy and anesthetics even somehow playing a role in the onset of inflammatory reactions. Early blockade of the inflammatory cascade is able to overcome these consequences of cancer treatment,” say the authors of the study.
Also, in their opinion, therapy is aimed at suppressing inflammation, is effective for patients who do not have cancer, but are carriers of accumulation of “sleeping” cancer cells.
Their tests showed that preoperative introduction nonsteroidal anti-inflammatory drug called Ketorolac stops the spread of cancer cells and contributes to a significant increase in the survival rate. The same effect was observed when using (preoperative) substances of resolvins synthesized from omega-3 polyunsaturated fatty acids. In this case, as follows from the report of researchers, the joint use of Ketorolac and resolving especially effectively prevents the activity of dormant tumor cells can result in cancer and tumor growth, likely after therapy.